Headlines Clinical Development Related Topics 
Drug Discovery World
APRIL 22, 2024
Kynos Therapeutics Founder and CSO Damian Mole said: “The headline data from this Phase I study have demonstrated KNS366 is safe and well tolerated at exposures that resulted in a high level of KMO enzyme inhibition.
pharmaphorum
JUNE 1, 2022
For Astellas, GO will discover high-affinity antibodies against the O-glycoprotein targets, with the Japanese drugmaker responsible for subsequent research activities, clinical development and commercialisation if they reach the market. The post Astellas taps GO’s glycoprotein platform with $783.5m deal appeared first on.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
FEBRUARY 10, 2023
Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient populations in trials were exposed.
The Pharma Data
MARCH 28, 2022
About the SUSTAIN clinical programme The SUSTAIN clinical development programme for once-weekly subcutaneous semaglutide injection currently comprises 11 phase 3 global clinical trials, including a cardiovascular outcomes trial, involving more than 11,000 adults with type 2 diabetes.
pharmaphorum
OCTOBER 14, 2020
The UK company made headlines earlier this year when partner Sumitomo Pharma started clinical trials of a drug candidate for obsessive compulsive disorder, said to be the first medicine developed using AI to enter testing in humans.
The Pharma Data
APRIL 28, 2022
Novo Nordisk today announced headline results from the ONWARDS 2 trial, a phase 3a, 26-week efficacy and safety treat-to-target trial investigating once-weekly insulin icodec vs insulin degludec in 526 people with type 2 diabetes switching from daily insulin.
XTalks
JANUARY 5, 2021
With COVID-19 having dominated the headlines in 2020, the coronavirus pandemic will inevitably continue to be the biggest story in 2021, but hopefully for more positive reasons. The burden of clinical trials is on all patient groups and patient segments. This includes how you engage with patients and how samples are collected.
Expert insights. Personalized for you.
52 
Let's personalize your content